secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indaptus Therapeutics, Inc. (INDP)
CIK:        0001857044
Form:       8-K
Filed at:   2025-06-26T23:59:59+00:00
Accession:  0001641172-25-016694
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Indaptus Therapeutics implements 1-for-28 reverse stock split effective June 26, 2025
--------------------------------------------------------------------------------

- Reverse stock split at ratio of 1-for-28 effective after market close on June 26, 2025.
- Trading on split-adjusted basis begins June 27, 2025; new CUSIP 45339J 204.
- Purpose is to regain Nasdaq continued listing compliance and attract institutional investors.
- Outstanding shares reduced from ~16 million to ~572 thousand; no change in authorized shares.
- Proportionate adjustments made to options, warrants; fractional shares paid in cash.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1857044/000164117225016694/0001641172-25-016694-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1857044/000164117225016694/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-016694

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer